Update on high-power short-duration ablation for pulmonary vein isolation

J Cardiovasc Electrophysiol. 2020 Sep;31(9):2499-2508. doi: 10.1111/jce.14649. Epub 2020 Jul 11.

Abstract

Pulmonary vein isolation (PVI) is the cornerstone of atrial fibrillation (AF) ablation. However, this procedure remains complex and time-consuming, and the recurrence of AF after PVI is still unsatisfactory. Current technologies have improved our knowledge of the association between radiofrequency lesion creation and ablation parameters (power and duration), which triggered the development of high-power short-duration (HPSD). During the past decade, several preclinical and clinical studies have been conducted to confirm the feasibility, safety, and outcome of PVI ablation with HPSD or very high-power short-duration (vHPSD) settings, which increased electrophysiologists' interests in the utility of HPSD strategies. This paper describes the theoretical basis and recent research findings of HPSD or vHPSD ablation and summarizes the state-of-the-art evidence behind the role of this strategy in PVI.

Keywords: atrial fibrillation; high-power short-duration; pulmonary vein isolation.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Atrial Fibrillation / diagnosis
  • Atrial Fibrillation / surgery
  • Catheter Ablation* / adverse effects
  • Humans
  • Pulmonary Veins* / surgery
  • Recurrence
  • Treatment Outcome